Alyeska Investment Group
TTOO

Alyeska Investment Group’s T2 Biosystems, Inc TTOO Stock Holding History

Alyeska Investment Group’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10
Closed -$386K – 483
2018
Q3 		$386K Sell
10
-51
-84% -$1.68M ﹤0.01% 384
2018
Q2 		$2.37M Buy
+61
New +$2.31M 0.02% 341

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Alyeska Investment Group's TTOO Position: Q4 2018 in Review

Alyeska Investment Group sold out of T2 Biosystems, Inc (TTOO) in Q4 2018, closing a stake of 10 shares — an estimated $386K sold.

Alyeska Investment Group first reported a position in TTOO in Q2 2018 and held it in 2 quarters. The position peaked at $2.37M in Q2 2018. 84 funds tracked by Wall St. Rank hold TTOO as of Q4 2018.

  • Alyeska Investment Group reported no remaining T2 Biosystems, Inc position as of Q4 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 10 T2 Biosystems, Inc shares in Q4 2018, an estimated $386K.
  • Alyeska Investment Group first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 2 quarters.
  • Alyeska Investment Group's T2 Biosystems, Inc position peaked at $2.37M in Q2 2018.
  • 84 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2018.

Based on Alyeska Investment Group's 13F filing for Q4 2018, filed 14 Feb 2019.